| 摘要 |
A method of treating a human suffering from one or more conditions included within the Coronary Heart Disease Risk Factor (CHDRF) syndrome. The method includes administering, by a pharmaceutically effective mode, a drug composition having an active ingredient which is selected from opiate antagonists, opiates having mu agonist activity and combinations thereof, including Loperamide, morphine derivatives, methadone, fentanyl, sufentanyl, etonitazene. |
